Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 6-MTH group results

Nov 12 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             16.45               17.37            33.90    
                 (-5.3 pct)          (+23.0 pct)      (-5.4 pct)  
  Operating          3.04                2.62             6.20    
                 (+15.7 pct)        (+280.9 pct)      (+13.5 pct) 
  Recurring          2.96                2.67             6.35    
                 (+10.9 pct)        (+248.5 pct)      (+12.1 pct) 
  Net                2.08                1.72             4.25    
                 (+20.6 pct)        (+468.5 pct)      (+16.2 pct) 
  EPS             17.23 yen           14.29 yen        35.29 yen  
  Ann Div                             7.00 yen         8.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             7.00 yen         8.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news